Searchable abstracts of presentations at key conferences in endocrinology

ea0050p387 | Thyroid | SFEBES2017

The Oxford Multidisciplinary Thyroid Eye Disease Clinic: Can short waiting times and use of Steroid Sparing Agents reduce total glucocorticoid dose and requirement for surgery/radiotherapy?

Turner Helen , David Joel , Norris Jonathan

Introduction: The Oxford multidisciplinary thyroid eye disease (TED) clinic comprising an oculoplastic surgeon, rheumatologist and endocrinologist with access to orthoptics, neuroradiology and radiotherapy was established in 2013. The aim of the service is to facilitate rapid referral and treatment in a specialist centre in keeping with the Amsterdam Declaration. Early use of steroid sparing agents (SSA) and recently rituximab form part of the treatment regimen.<...

ea0050p387 | Thyroid | SFEBES2017

The Oxford Multidisciplinary Thyroid Eye Disease Clinic: Can short waiting times and use of Steroid Sparing Agents reduce total glucocorticoid dose and requirement for surgery/radiotherapy?

Turner Helen , David Joel , Norris Jonathan

Introduction: The Oxford multidisciplinary thyroid eye disease (TED) clinic comprising an oculoplastic surgeon, rheumatologist and endocrinologist with access to orthoptics, neuroradiology and radiotherapy was established in 2013. The aim of the service is to facilitate rapid referral and treatment in a specialist centre in keeping with the Amsterdam Declaration. Early use of steroid sparing agents (SSA) and recently rituximab form part of the treatment regimen.<...

ea0049gp203 | Thyroid 1 | ECE2017

The oxford multidisciplinary thyroid eye disease (TED) clinic; can short waiting times and use of steroid sparing agents (SSA) reduce total steroid dose and requirement for surgery/radiotherapy?

Turner Helen , David Joel , Norris Jonathan

Introduction: The Oxford multidisciplinary thyroid eye disease (TED) clinic comprising an oculoplastic surgeon, rheumatologist and endocrinologist with access to orthoptics, neuroradiology and radiotherapy was established in 2013. The aim was to facilitate rapid referral and treatment in a specialist centre in keeping with Amsterdam Declaration. Early use of steroid sparing agents (SSA) and recently rituximab forms part of the treatment regimen.Methods: ...

ea0031p117 | Clinical practice/governance and case reports | SFEBES2013

Clinical practice hyperaldosteronism: a misleading adrenal tumor

Verlekar Pankaj , Norris Andrea , Chong Jimmy

Background: A 58-year-old male known to have hypertension since 2002 was initially treated with Furosemide and Bendroflumethiazide but was stopped due to hypokalemia. Blood pressure was controlled with Ramipril, Atenolol, Doxazocin and Amlodepine. He was found to be persistently hypokalemia ranging from 2.7 to 3.3 mmol/l.Investigations: Aldosterone: 250 ng/l, renin: <2.3 mU/l, aldosterone:renin ratio: >108, 24 h urine catecholamines×2: norma...

ea0019p54 | Clinical practice/governance and case reports | SFEBES2009

Tertiary hyperparathyroidism in pregnant women with vitamin D deficiency

Kenz Sami , Norris Andrea , Chohan Zak

Introduction: Hyperparathyroidism is uncommon during pregnancy with less than 200 cases reported worldwide. Untreated, this condition can result in a 20–30% incidence of fetal death and 50–60% incidence of complications during pregnancy. If recognized early, the condition is treatable with significant improvement in fetal and maternal outcomes.Case: We report the case of 35-year-old asymptomatic Asian female (gravida 9 para 4, one stillbirth) w...

ea0062p62 | Poster Presentations | EU2019

A case of a TSH-secreting pituitary macroadenoma in a previously well thirty year old woman

Golding Jonathan , Canagon Sara , Norris John , Chakera Ali

Case History: A thirty year old female presented to hospital after a first seizure. She had no significant past medical history. She had a one week history of recurrent frontal headaches and had noticed irregular periods. There were no clinical features of acromegaly. CT and MRI brain imaging showed a 5 cm mass arising from the pituitary fossa, extending into the suprasellar cistern and anterior cranial fossa. There was evidence of mass effect on the optic nerves and optic chi...

ea0049gp63 | Developmental &amp; Protein Endocrinology | ECE2017

Does the loss of RAD52 in PC contribute to resistance to antiandrogen therapy?

Alfaqih Mahmoud A. , Chang Ching yi , Norris John , McDonnell Donald P.

Recent statistics indicate that prostate cancer (PC) is the most frequent cancer in men worldwide and is the leading cause of cancer death in men above 50 years of age. The Androgen receptor (AR), a member of the superfamily of nuclear hormone receptors, plays a well-established role in the development and progression of the disease. PC localized to the prostate is commonly treated with surgical removal of the gland and is often associated with a favorable outcome. However, me...

ea0049gp206 | Thyroid 2 | ECE2017

Early use of steroid-sparing agents in treatment of moderate-to-severely active thyroid eye disease

Sipkova Zuzana , David Joel , Turner Helen , Norris Jonathan

Introduction: The management of active thyroid eye disease (TED) remains controversial. High dose intravenous methylprednisolone (IVMP) is the current recommended first-line treatment based on EUGOGO guidance. Such therapy has the potential for serious adverse effects. We present the outcomes of an alternative approach in the management of moderate-to-severely active TED, using steroid-sparing agents (SSAs) in conjunction with IVMP. Methotrexate is used as the first-line SSA a...

ea0038p143 | Growth and development | SFEBES2015

Vitamin D promotes myogenic differentiation and induces an antifibrotic phenotype in primary cultures of skeletal muscle derived satellite cells and fibroblasts

Daoud Amanda , Kim Irene , Norris Keith , Ferrini Monica , Artaza Jorge

Purpose of study: Skeletal muscle wasting is a serious public health problem associated with aging, chronic kidney disease, and AIDS. Vitamin D (VD) is most widely recognised for its regulation of calcium and phosphate homeostasis in relation to bone development and maintenance and for its synergistic effects on target organs such as PTH glands. Recently, it has been shown to improve muscle performance and reduce falls in VD deficient older adults. However, little is known of ...

ea0028p95 | Clinical practice/governance and case reports | SFEBES2012

Recurrent atypical adrenocorticotrophic hormone (ACTH) secreting carcinoid tumour causing Cushing’s syndrome

Mlawa Gideon , Lambert Kimberley , Norris Andrea , Li Voon Chong Jimmy

Background: Atypical carcinoid tumours are rare which account for about 15% of all carcinoid tumours. Some of those tumours secrete adrenocorticotrophic hormone (ACTH) causing Cushing's syndrome. We present a case which recurred 16 years after being first diagnosed.Case: A 39 years old woman was referred with few months history of weight gain, irregular menstrual periods, muscle aches, difficult going up the stairs, headaches and blurred vision.She was i...